Urology Devices Market by Product (Dialysis, Laser, Lithotripsy, Robotic, Insufflators, Guidewires, Catheters, Stents, Implants), Application (Kidney Diseases, Cancer, Pelvic Organ Prolapse, BPH, Stones), End User and Region - Global Forecast to 2030

1 INTRODUCTION 26 1.1 STUDY OBJECTIVES 26 1.2 MARKET DEFINITION 26 1.3 STUDY SCOPE 27 1.3.1 MARKETS COVERED 27 1.3.2 INCLUSIONS AND EXCLUSIONS 28 1.3.3 YEARS CONSIDERED 29 1.4 CURRENCY CONSIDERED 30 1.5 STAKEHOLDERS 30 1.6 SUMMARY OF CHANGES 30 2 RESEARCH METHODOLOGY 32 2.1 RESEARCH DATA 32 2.1.1 SECONDARY DATA 33 2.1.1.1 Key secondary sources 33 2.1.1.2 List of key secondary sources 33 2.1.1.3 Key data from secondary sources 34 2.1.2 PRIMARY DATA 34 2.1.2.1 Key objectives of primary research 34 2.1.2.2 List of primary sources 35 2.1.2.3 Key data from primary sources 35 2.1.2.4 Breakdown of primary interviews 36 2.1.2.5 Insights from industry experts 37 2.2 MARKET SIZE ESTIMATION 37 2.2.1 BOTTOM-UP APPROACH 37 2.2.1.1 Revenue estimation of key players 38 2.2.1.2 Annual reports and investor presentations 38 2.2.1.3 Primary interviews 38 2.2.1.4 Growth forecast 38 2.2.1.5 CAGR projections 39 2.2.2 TOP-DOWN APPROACH 39 2.3 DATA TRIANGULATION 40 2.4 RESEARCH ASSUMPTIONS 41 2.4.1 PARAMETRIC ASSUMPTIONS 41 2.4.2 GROWTH RATE ASSUMPTIONS 41 2.4.3 SCOPE-RELATED ASSUMPTIONS 42 2.5 RESEARCH LIMITATIONS 42 2.6 RISK ANALYSIS 42 3 EXECUTIVE SUMMARY 43 4 PREMIUM INSIGHTS 47 4.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN UROLOGY DEVICES MARKET 47 4.2 ASIA PACIFIC UROLOGY DEVICES MARKET, BY END USER AND COUNTRY 48 4.3 UROLOGY DEVICES MARKET, BY COUNTRY 49 4.4 UROLOGY DEVICES MARKET, BY REGION 50 5 MARKET OVERVIEW 51 5.1 INTRODUCTION 51 5.2 MARKET DYNAMICS 51 5.2.1 DRIVERS 51 5.2.1.1 Rising incidence of urological diseases 51 5.2.1.2 Growing preference for minimally invasive procedures 53 5.2.1.3 Technological advancements and increased R&D investments 54 5.2.1.4 Increasing number of hospitals and surgical centers 55 5.2.2 RESTRAINTS 55 5.2.2.1 High degree of consolidation among key players 55 5.2.3 OPPORTUNITIES 56 5.2.3.1 Potential growth opportunities in emerging economies 56 5.2.4 CHALLENGES 57 5.2.4.1 Increasing number of product recalls by key players 57 5.2.4.2 Shortage of urologists and trained professionals 57 5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESS 58 5.4 PRICING ANALYSIS 59 5.4.1 AVERAGE SELLING PRICE TREND, BY TYPE 59 5.4.2 AVERAGE SELLING PRICE TREND, BY KEY PLAYER 59 5.4.3 AVERAGE SELLING PRICE TREND, BY REGION 60 5.5 VALUE CHAIN ANALYSIS 61 5.6 SUPPLY CHAIN ANALYSIS 62 5.7 ECOSYSTEM ANALYSIS 63 5.8 INVESTMENT AND FUNDING SCENARIO 65 5.9 TECHNOLOGY ANALYSIS 65 5.9.1 KEY TECHNOLOGIES 65 5.9.1.1 Antimicrobial-coated catheters 65 5.9.1.2 Portable hemodialysis 66 5.9.2 COMPLEMENTARY TECHNOLOGIES 66 5.9.2.1 Smart catheters 66 5.9.2.2 Connected health & remote sensors 67 5.9.3 ADJACENT TECHNOLOGIES 67 5.9.3.1 Wearable artificial kidney 67 5.10 PATENT ANALYSIS 67 5.11 TRADE ANALYSIS 69 5.11.1 IMPORT DATA FOR HS CODE 841920 69 5.11.2 EXPORT DATA FOR HS CODE 841920 70 5.12 KEY CONFERENCES AND EVENTS, 2025–2026 70 5.13 REGULATORY ANALYSIS 71 5.13.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 71 5.13.2 REGULATORY FRAMEWORK 73 5.13.2.1 North America 73 5.13.2.1.1 US 73 5.13.2.1.2 Canada 73 5.13.2.2 Europe 73 5.13.2.3 Asia Pacific 73 5.13.2.3.1 China 73 5.13.2.3.2 Japan 74 5.13.2.3.3 India 74 5.13.2.4 Latin America 74 5.13.2.4.1 Brazil 74 5.13.2.4.2 Mexico 75 5.13.2.5 Middle East 75 5.13.2.6 Africa 75 5.14 PORTER’S FIVE FORCES ANALYSIS 75 5.14.1 BARGAINING POWER OF SUPPLIERS 77 5.14.2 BARGAINING POWER OF BUYERS 77 5.14.3 THREAT OF NEW ENTRANTS 77 5.14.4 THREAT OF SUBSTITUTES 78 5.14.5 INTENSITY OF COMPETITIVE RIVALRY 78 5.15 KEY STAKEHOLDERS AND BUYING CRITERIA 78 5.15.1 KEY STAKEHOLDERS IN BUYING PROCESS 79 5.15.2 KEY BUYING CRITERIA 79 5.16 IMPACT OF AI/GEN AI ON UROLOGY DEVICES MARKET 80 5.16.1 INTRODUCTION 80 5.16.2 POTENTIAL OF AI 80 5.16.3 IMPACT OF AI 81 5.16.4 KEY COMPANIES IMPLEMENTING AI 81 5.16.5 FUTURE OF AI 82 5.17 IMPACT OF 2025 US TARIFF ON UROLOGY DEVICES MARKET 82 5.17.1 INTRODUCTION 82 5.17.2 KEY TARIFF RATES 82 5.17.3 PRICE IMPACT ANALYSIS 83   5.17.4 IMPACT ON COUNTRY/REGION 84 5.17.4.1 North America 84 5.17.4.2 Europe 84 5.17.4.3 Asia Pacific 84 5.17.5 IMPACT ON END-USE INDUSTRIES 85 5.17.5.1 Hospitals 85 5.17.5.2 Clinics 85 5.17.5.3 Ambulatory Surgical Centers (ASCs) 85 5.17.5.4 Dialysis centers 86 5.17.5.5 Home care settings 86 6 UROLOGY DEVICES MARKET, BY PRODUCT 87 6.1 INTRODUCTION 88 6.2 INSTRUMENTS 88 6.2.1 DIALYSIS DEVICES 90 6.2.1.1 Hemodialysis devices 91 6.2.1.1.1 Increasing use of dialysis machines to spur growth 91 6.2.1.2 Peritoneal dialysis devices 92 6.2.1.2.1 Rising technological advancements and increasing product approvals to propel market 92 6.2.2 ENDOSCOPES 93 6.2.2.1 Laparoscopes 94 6.2.2.1.1 Lower surgical site infections to support growth 94 6.2.2.2 Ureteroscopes 95 6.2.2.2.1 Increased usage of ureteroscopy for kidney stones to drive market 95 6.2.2.3 Nephroscopes 97 6.2.2.3.1 High cost of maintenance to restrain market growth 97 6.2.2.4 Resectoscopes 97 6.2.2.4.1 High prevalence of prostate, kidney, and bladder cancers to fuel market 97 6.2.2.5 Cystoscopes 98 6.2.2.5.1 Growing incidence of urological cancers to boost market 98 6.2.3 LASER & LITHOTRIPSY DEVICES 99 6.2.3.1 Associated benefits of lithotripsy devices to support growth 99 6.2.4 ENDOVISION & IMAGING SYSTEMS 101 6.2.4.1 Need for high-resolution images to aid growth 101 6.2.5 ROBOTIC SYSTEMS 102 6.2.5.1 Growing industry-academia collaborations to fuel market 102 6.2.6 INSUFFLATORS 103 6.2.6.1 Increasing volume of laparoscopic procedures to boost market 103 6.2.7 ENDOSCOPY FLUID MANAGEMENT SYSTEMS 104 6.2.7.1 Growing incidence of chronic diseases to drive market 104 6.2.8 URODYNAMIC SYSTEMS 105 6.2.8.1 Rising patient pool to support growth 105 6.2.9 OTHER INSTRUMENTS 106 6.3 CONSUMABLES & ACCESSORIES 107 6.3.1 DIALYSIS CONSUMABLES 108 6.3.1.1 Growing number of dialysis procedures to fuel market 108 6.3.2 CATHETERS 109 6.3.2.1 Intermittent catheters 110 6.3.2.1.1 Rising clinical adoption of intermittent catheters to support growth 110 6.3.2.2 Indwelling catheters 112 6.3.2.2.1 Increased use in hospitals and home care settings to facilitate growth 112 6.3.2.3 External catheters 113 6.3.2.3.1 Growing preference for home-based management of chronic urinary conditions to drive market 113 6.3.3 GUIDEWIRES 114 6.3.3.1 Increasing number of surgeries and development of next-generation hybrid guidewires to drive market 114 6.3.4 RETRIEVAL DEVICES & EXTRACTORS 114 6.3.4.1 Growing number of kidney stone removal surgeries to fuel market 114 6.3.5 SURGICAL DISSECTORS, FORCEPS & NEEDLE HOLDERS 115 6.3.5.1 Rise in urology procedures to support growth 115 6.3.6 DILATOR SETS & URETHRAL ACCESS SHEATHS 116 6.3.6.1 Increasing demand for effective endoscopic management of ureteral and renal calculi to aid growth 116 6.3.7 STENTS & IMPLANTS 117 6.3.7.1 Growing prevalence of urological, kidney-related disorders, and erectile dysfunction to propel market 117 6.3.8 BIOPSY DEVICES 118 6.3.8.1 High incidence of prostate cancer to contribute to growth 118 6.3.9 TUBES & DISTAL ATTACHMENTS 119 6.3.9.1 Increasing demand for endoscopy to boost market 119 6.3.10 DRAINAGE BAGS 120 6.3.10.1 Increasing prevalence of urinary incontinence and chronic kidney disease to foster growth 120 6.3.11 OTHER CONSUMABLES & ACCESSORIES 121 7 UROLOGY DEVICE MARKET, BY APPLICATION 123 7.1 INTRODUCTION 124 7.2 KIDNEY DISEASES 124 7.2.1 GROWING PREVALENCE OF DIABETES AND HYPERTENSION TO DRIVE MARKET 124 7.3 UROLOGICAL CANCER 125 7.3.1 RISING PREVALENCE OF UROLOGICAL CANCER TO CONTRIBUTE TO GROWTH 125 7.4 PELVIC ORGAN PROLAPSE 126 7.4.1 HIGH COSTS INVOLVED IN SURGERIES & HIGH REOCCURRENCE RATES TO RESTRAIN GROWTH 126 7.5 BENIGN PROSTATIC HYPERPLASIA (BPH) 127 7.5.1 INCREASING ELDERLY POPULATION TO AID GROWTH 127 7.6 URINARY INCONTINENCE (UI) 128 7.6.1 NEED FOR PROPER DIAGNOSIS AND TREATMENT TO SUPPORT GROWTH 128 7.7 ERECTILE DYSFUNCTION 129 7.7.1 INCREASING PREVALENCE OF PROSTATE CANCER TO AID GROWTH 129 7.8 URINARY STONES 130 7.8.1 GROWING PREFERENCE FOR MINIMALLY INVASIVE PROCEDURES TO FUEL MARKET 130 7.9 OTHER APPLICATIONS 131 8 UROLOGY DEVICES MARKET - EPIDEMIOLOGY AND PREVALENCE ANALYSIS, 2023-2030 (NO. OF CASES/PREVALENCE) 133 9 UROLOGY DEVICES MARKET, BY END USER 134 9.1 INTRODUCTION 135 9.2 HOSPITALS 135 9.2.1 INCREASING NUMBER OF HOSPITALS IN EMERGING ECONOMIES TO EXPEDITE GROWTH 135 9.3 AMBULATORY SURGERY CENTERS 137 9.3.1 LOWER COST AND SHORTER PATIENT STAYS TO PROMOTE GROWTH 137 9.4 CLINICS 138 9.4.1 GROWING INTEGRATION OF ADVANCED TECHNOLOGY IN UROLOGY CLINICS TO PROPEL MARKET 138 9.5 DIALYSIS CENTERS 139 9.5.1 RISING DEMAND FOR ADVANCED DIALYSIS AND END-STAGE RENAL DISEASE TREATMENTS TO AID GROWTH 139 9.6 HOME CARE SETTINGS 140 9.6.1 LOWER COST AND SHORTER HOSPITAL STAYS TO BOOST MARKET 140 10 UROLOGY DEVICES MARKET, BY REGION 142 10.1 INTRODUCTION 143 10.2 NORTH AMERICA 143 10.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 144 10.2.2 US 147 10.2.2.1 Presence of large dialysis patient base and robust infrastructure to promote growth 147 10.2.3 CANADA 151 10.2.3.1 Increasing focus on preventing target diseases to expedite growth 151   10.3 EUROPE 154 10.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 155 10.3.2 GERMANY 157 10.3.2.1 Presence of major urology device manufacturers to contribute to growth 157 10.3.3 UK 161 10.3.3.1 Rising incidence of kidney conditions to bolster growth 161 10.3.4 FRANCE 164 10.3.4.1 Favorable government initiatives and shifting demographic trends to aid growth 164 10.3.5 ITALY 167 10.3.5.1 Increasing cases of chronic diseases to spur growth 167 10.3.6 SPAIN 170 10.3.6.1 Rising geriatric population to accelerate growth 170 10.3.7 REST OF EUROPE 173 10.4 ASIA PACIFIC 176 10.4.1 MACROECONOMIC OUTLOOK 177 10.4.2 CHINA 179 10.4.2.1 Rising incidence of target health conditions and decreasing mortality rate to facilitate growth 179 10.4.3 JAPAN 182 10.4.3.1 Large geriatric population and established healthcare system to support growth 182 10.4.4 INDIA 185 10.4.4.1 Large patient pool and rapidly growing healthcare sector to drive market 185 10.4.5 REST OF ASIA PACIFIC 189 10.5 LATIN AMERICA 192 10.5.1 MACROECONOMIC OUTLOOK 192 10.5.2 BRAZIL 194 10.5.2.1 Rising cases of metabolic diseases to support growth 194 10.5.3 MEXICO 197 10.5.3.1 Increasing prevalence of diabetes and kidney disorders to expedite growth 197 10.5.4 REST OF LATIN AMERICA 200 10.6 MIDDLE EAST & AFRICA 203 10.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 204   11 COMPETITIVE LANDSCAPE 206 11.1 OVERVIEW 206 11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2022–2025 206 11.3 REVENUE ANALYSIS, 2022–2024 207 11.4 MARKET SHARE ANALYSIS, 2024 208 11.5 COMPANY VALUATION AND FINANCIAL METRICS 211 11.6 BRAND/PRODUCT COMPARISON 212 11.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 213 11.7.1 STARS 213 11.7.2 EMERGING LEADERS 213 11.7.3 PERVASIVE PLAYERS 213 11.7.4 PARTICIPANTS 213 11.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024 214 11.7.5.1 Company footprint 214 11.7.5.2 Region footprint 215 11.7.5.3 Product footprint 215 11.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024 215 11.8.1 PROGRESSIVE COMPANIES 215 11.8.2 RESPONSIVE COMPANIES 216 11.8.3 DYNAMIC COMPANIES 216 11.8.4 STARTING BLOCKS 216 11.8.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024 217 11.8.5.1 Detailed list of key startups/SMEs 217 11.8.5.2 Competitive benchmarking of key startups/SMEs 217 11.9 COMPETITIVE SCENARIO 217 11.9.1 PRODUCT LAUNCHES AND APPROVALS 217 11.9.2 DEALS 219 11.9.3 EXPANSIONS 220 12 COMPANY PROFILES 221 12.1 KEY PLAYERS 221 12.1.1 FRESENIUS MEDICAL CARE AG & CO. KGAA 221 12.1.1.1 Business overview 221 12.1.1.2 Products offered 222 12.1.1.3 Recent developments 223 12.1.1.3.1 Deals 223 12.1.1.3.2 Expansions 223 12.1.1.4 MnM view 223 12.1.1.4.1 Key strengths 223 12.1.1.4.2 Strategic choices 223 12.1.1.4.3 Weaknesses and competitive threats 224   12.1.2 BOSTON SCIENTIFIC CORPORATION 225 12.1.2.1 Business overview 225 12.1.2.2 Products offered 226 12.1.2.3 Recent developments 228 12.1.2.3.1 Product launches and approvals 228 12.1.2.3.2 Deals 229 12.1.2.4 MnM view 229 12.1.2.4.1 Key strengths 229 12.1.2.4.2 Strategic choices 229 12.1.2.4.3 Weaknesses and competitive threats 229 12.1.3 B. BRAUN MELSUNGEN AG 230 12.1.3.1 Business overview 230 12.1.3.2 Products offered 231 12.1.3.3 Recent developments 233 12.1.3.3.1 Deals 233 12.1.3.4 MnM view 233 12.1.3.4.1 Key strengths 233 12.1.3.4.2 Strategic choices 233 12.1.3.4.3 Weaknesses and competitive threats 233 12.1.4 BECTON, DICKINSON AND COMPANY 234 12.1.4.1 Business overview 234 12.1.4.2 Products offered 235 12.1.4.3 MnM view 238 12.1.4.3.1 Key strengths 238 12.1.4.3.2 Strategic choices 238 12.1.4.3.3 Weaknesses and competitive threats 238 12.1.5 OLYMPUS CORPORATION 239 12.1.5.1 Business overview 239 12.1.5.2 Products offered 240 12.1.5.3 Recent developments 243 12.1.5.3.1 Product launches and approvals 243 12.1.5.3.2 Deals 243 12.1.5.3.3 Expansions 243 12.1.6 CARDINAL HEALTH 244 12.1.6.1 Business overview 244 12.1.6.2 Products offered 245 12.1.6.3 Recent developments 246 12.1.6.3.1 Deals 246 12.1.7 INTUITIVE SURGICAL 247 12.1.7.1 Business overview 247 12.1.7.2 Products offered 248 12.1.7.3 Recent developments 249 12.1.7.3.1 Product launches and approvals 249 12.1.8 COLOPLAST A/S 250 12.1.8.1 Business overview 250 12.1.8.2 Products offered 251 12.1.8.3 Recent developments 253 12.1.8.3.1 Product launches and approvals 253 12.1.9 STRYKER 254 12.1.9.1 Business overview 254 12.1.9.2 Products offered 255 12.1.9.3 Recent developments 256 12.1.9.3.1 Product launches and approvals 256 12.1.10 TELEFLEX INCORPORATED 257 12.1.10.1 Business overview 257 12.1.10.2 Products offered 258 12.1.10.3 Recent developments 261 12.1.10.3.1 Product launches and approvals 261 12.1.11 CONVATEC GROUP PLC 262 12.1.11.1 Business overview 262 12.1.11.2 Products offered 263 12.1.12 MEDTRONIC PLC 264 12.1.12.1 Business overview 264 12.1.12.2 Products offered 265 12.1.12.3 Recent developments 266 12.1.12.3.1 Expansions 266 12.2 OTHER PLAYERS 267 12.2.1 KARL STORZ 267 12.2.2 COOK MEDICAL 268 12.2.3 RICHARD WOLF GMBH 271 12.2.4 COMPACTCATH 272 12.2.5 DORNIER MEDTECH 273 12.2.6 NIKKISO CO., LTD. 274 12.2.7 DIALIFE SA 275 12.2.8 ERBE VISION 276 12.2.9 WELL LEAD MEDICAL CO., LTD. 277 12.2.10 ROCAMED 278 12.2.11 ENDOMED SYSTEMS GMBH 279 12.2.12 AMSINO INTERNATIONAL, INC. 280 12.2.13 MEDISPEC 281 12.2.14 VIMEX SP. Z O. O. 282 12.2.15 BALTON SP. Z O.O. 283 12.2.16 HUNTER UROLOGY 284 12.2.17 RIBBEL INTERNATIONAL LIMITED 285 13 APPENDIX 286 13.1 DISCUSSION GUIDE 286 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 289 13.3 CUSTOMIZATION OPTIONS 291 13.4 RELATED REPORTS 291 13.5 AUTHOR DETAILS 292

TABLE 1 UROLOGY DEVICES MARKET: SCOPE-RELATED ASSUMPTIONS 42 TABLE 2 UROLOGY DEVICES MARKET: RISK ANALYSIS 42 TABLE 3 GLOBAL INCIDENCE OF UROLOGICAL CANCER, 2022 52 TABLE 4 LIST OF PRODUCT RECALLS BY KEY PLAYERS, 2022–2023 57 TABLE 5 AVERAGE SELLING PRICING TREND OF UROLOGY DEVICES, BY TYPE, 2023–2025 (USD) 59 TABLE 6 AVERAGE SELLING PRICE TREND OF UROLOGY DEVICES, BY KEY PLAYER, 2023–2025 (USD) 60 TABLE 7 AVERAGE SELLING PRICE TREND OF UROLOGY DEVICES PRODUCTS, BY REGION, 2023–2025 (USD) 60 TABLE 8 UROLOGY DEVICES MARKET: ROLE OF KEY PLAYERS IN ECOSYSTEM 64 TABLE 9 KEY PATENTS IN UROLOGY DEVICES MARKET, 2022–2025 68 TABLE 10 IMPORT DATA FOR HS CODE 901890, BY COUNTRY, 2020–2024 (USD MILLION) 69 TABLE 11 EXPORT DATA FOR HS CODE 901890, BY COUNTRY, 2020–2024 (USD MILLION) 70 TABLE 12 UROLOGY DEVICES MARKET: KEY CONFERENCES AND EVENTS, JANUARY 2025–DECEMBER 2026 70 TABLE 13 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 71 TABLE 14 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 72 TABLE 15 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 72 TABLE 16 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 72 TABLE 17 UROLOGY DEVICES MARKET: IMPACT OF PORTER’S FIVE FORCES 76 TABLE 18 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE END USERS (%) 79 TABLE 19 KEY BUYING CRITERIA FOR TOP THREE END USERS 80 TABLE 20 KEY COMPANIES IMPLEMENTING AI IN UROLOGY DEVICES MARKET 81 TABLE 21 US ADJUSTED RECIPROCAL TARIFF RATES 82 TABLE 22 UROLOGY DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 88 TABLE 23 UROLOGY DEVICES MARKET FOR INSTRUMENTS, BY REGION, 2023–2030 (USD MILLION) 89 TABLE 24 UROLOGY DEVICES MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION) 89 TABLE 25 UROLOGY DEVICES MARKET FOR DIALYSIS DEVICES, BY REGION, 2023–2030 (USD MILLION) 90 TABLE 26 UROLOGY DEVICES MARKET FOR DIALYSIS DEVICES, BY TYPE, 2023–2030 (USD MILLION) 91 TABLE 27 UROLOGY DEVICES MARKET FOR HEMODIALYSIS DEVICES, BY REGION, 2023–2030 (USD MILLION) 92 TABLE 28 UROLOGY DEVICES MARKET FOR PERITONEAL DIALYSIS DEVICES, BY REGION, 2023–2030 (USD MILLION) 93 TABLE 29 UROLOGY DEVICES MARKET FOR ENDOSCOPES, BY REGION, 2023–2030 (USD MILLION) 94 TABLE 30 UROLOGY DEVICES MARKET FOR ENDOSCOPES, BY TYPE, 2023–2030 (USD MILLION) 94 TABLE 31 UROLOGY DEVICES MARKET FOR LAPAROSCOPES, BY REGION, 2023–2030 (USD MILLION) 95 TABLE 32 UROLOGY DEVICES MARKET FOR URETEROSCOPES, BY REGION, 2023–2030 (USD MILLION) 96 TABLE 33 UROLOGY DEVICES MARKET FOR NEPHROSCOPES, BY REGION, 2023–2030 (USD MILLION) 97 TABLE 34 UROLOGY DEVICES MARKET FOR RESECTOSCOPES, BY REGION, 2023–2030 (USD MILLION) 98 TABLE 35 UROLOGY DEVICES MARKET FOR CYSTOSCOPES, BY REGION, 2023–2030 (USD MILLION) 99 TABLE 36 UROLOGY DEVICES MARKET FOR LASER & LITHOTRIPSY DEVICES, BY REGION, 2023–2030 (USD MILLION) 100 TABLE 37 UROLOGY DEVICES MARKET FOR ENDOVISION & IMAGING SYSTEMS, BY REGION, 2023–2030 (USD MILLION) 102 TABLE 38 UROLOGY DEVICES MARKET FOR ROBOTIC SYSTEMS, BY REGION, 2023–2030 (USD MILLION) 103 TABLE 39 UROLOGY DEVICES MARKET FOR INSUFFLATORS, BY REGION, 2023–2030 (USD MILLION) 104 TABLE 40 UROLOGY DEVICES MARKET FOR ENDOSCOPY FLUID MANAGEMENT SYSTEMS, BY REGION, 2023–2030 (USD MILLION) 105 TABLE 41 UROLOGY DEVICES MARKET FOR URODYNAMIC SYSTEMS, BY REGION, 2023–2030 (USD MILLION) 106 TABLE 42 UROLOGY DEVICES MARKET FOR OTHER INSTRUMENTS, BY REGION, 2023–2030 (USD MILLION) 107 TABLE 43 UROLOGY DEVICES MARKET FOR CONSUMABLES & ACCESSORIES, BY REGION, 2023–2030 (USD MILLION) 107 TABLE 44 UROLOGY DEVICES MARKET FOR CONSUMABLES & ACCESSORIES, BY TYPE, 2023–2030 (USD MILLION) 108 TABLE 45 UROLOGY DEVICES MARKET FOR DIALYSIS CONSUMABLES, BY REGION, 2023–2030 (USD MILLION) 109 TABLE 46 UROLOGY DEVICES MARKET FOR CATHETERS, BY REGION, 2023–2030 (USD MILLION) 110 TABLE 47 UROLOGY DEVICES MARKET FOR CATHETERS, BY TYPE, 2023–2030 (USD MILLION) 110 TABLE 48 UROLOGY DEVICES MARKET FOR INTERMITTENT CATHETERS, BY REGION, 2023–2030 (USD MILLION) 111 TABLE 49 UROLOGY DEVICES MARKET FOR INDWELLING CATHETERS, BY REGION, 2023–2030 (USD MILLION) 112 TABLE 50 UROLOGY DEVICES MARKET FOR EXTERNAL CATHETERS, BY REGION, 2023–2030 (USD MILLION) 113 TABLE 51 UROLOGY DEVICES MARKET FOR GUIDEWIRES, BY REGION, 2023–2030 (USD MILLION) 114 TABLE 52 UROLOGY DEVICES MARKET FOR RETRIEVAL DEVICES & EXTRACTORS, BY REGION, 2023–2030 (USD MILLION) 115 TABLE 53 UROLOGY DEVICES MARKET FOR SURGICAL DISSECTORS, FORCEPS & NEEDLE HOLDERS, BY REGION, 2023–2030 (USD MILLION) 116 TABLE 54 UROLOGY DEVICES MARKET FOR DILATOR SETS & URETHRAL ACCESS SHEATHS, BY REGION, 2023–2030 (USD MILLION) 117 TABLE 55 UROLOGY DEVICES MARKET FOR STENTS & IMPLANTS, BY REGION, 2023–2030 (USD MILLION 118 TABLE 56 UROLOGY DEVICES MARKET FOR BIOPSY DEVICES, BY REGION, 2023–2030 (USD MILLION) 119 TABLE 57 UROLOGY DEVICES MARKET FOR TUBES & DISTAL ATTACHMENTS, BY REGION, 2023–2030 (USD MILLION) 120 TABLE 58 UROLOGY DEVICES MARKET FOR DRAINAGE BAGS, BY REGION, 2023–2030 (USD MILLION) 121 TABLE 59 UROLOGY DEVICES MARKET FOR OTHER CONSUMABLES & ACCESSORIES, BY REGION, 2023–2030 (USD MILLION) 122 TABLE 60 UROLOGY DEVICES MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 124 TABLE 61 UROLOGY DEVICES MARKET FOR KIDNEY DISEASES, BY REGION, 2023–2030 (USD MILLION) 125 TABLE 62 UROLOGY DEVICES MARKET FOR UROLOGICAL CANCER, BY REGION, 2023–2030 (USD MILLION) 126 TABLE 63 UROLOGY DEVICES MARKET FOR PELVIC ORGAN PROLAPSE, BY REGION, 2023–2030 (USD MILLION) 127 TABLE 64 UROLOGY DEVICES MARKET FOR BENIGN PROSTATIC HYPERPLASIA (BPH), BY REGION, 2023–2030 (USD MILLION) 128 TABLE 65 UROLOGY DEVICES MARKET FOR BENIGN URINARY INCONTINENCE (UI), BY REGION, 2023–2030 (USD MILLION) 129 TABLE 66 UROLOGY DEVICES MARKET FOR ERECTILE DYSFUNCTION, BY REGION, 2023–2030 (USD MILLION) 130 TABLE 67 UROLOGY DEVICES MARKET FOR URINARY STONES, BY REGION, 2023–2030 (USD MILLION) 131 TABLE 68 UROLOGY DEVICES MARKET FOR OTHER APPLICATIONS, BY REGION, 2023–2030 (USD MILLION) 132 TABLE 69 UROLOGY DEVICES MARKET: PREVALENCE OF EPIDEMIOLOGY, BY APPLICATION, 2023–2030 133 TABLE 70 UROLOGY DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 135 TABLE 71 UROLOGY DEVICES MARKET FOR HOSPITALS, BY REGION, 2023–2030 (USD MILLION) 136 TABLE 72 UROLOGY DEVICES MARKET FOR AMBULATORY SURGERY CENTERS, BY REGION, 2023–2030 (USD MILLION) 138 TABLE 73 UROLOGY DEVICES MARKET FOR CLINICS, BY REGION, 2023–2030 (USD MILLION) 139 TABLE 74 UROLOGY DEVICES MARKET FOR DIALYSIS CENTERS, BY REGION, 2023–2030 (USD MILLION) 140 TABLE 75 UROLOGY DEVICES MARKET FOR HOME CARE SETTINGS, BY REGION, 2023–2030 (USD MILLION) 141 TABLE 76 UROLOGY DEVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 143 TABLE 77 NORTH AMERICA: KEY MACROECONOMIC INDICATORS 144 TABLE 78 NORTH AMERICA: UROLOGY DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 145 TABLE 79 NORTH AMERICA: UROLOGY DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 146 TABLE 80 NORTH AMERICA: UROLOGY DEVICES MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 146 TABLE 81 NORTH AMERICA: UROLOGY DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 147 TABLE 82 US: UROLOGY DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 148 TABLE 83 US: UROLOGY DEVICES MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION) 149 TABLE 84 US: UROLOGY DEVICES MARKET FOR CONSUMABLES & ACCESSORIES, BY TYPE, 2023–2030 (USD MILLION) 150 TABLE 85 US: UROLOGY DEVICES MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 150 TABLE 86 US: UROLOGY DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 151 TABLE 87 CANADA: UROLOGY DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 152 TABLE 88 CANADA: UROLOGY DEVICES MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION) 152 TABLE 89 CANADA: UROLOGY DEVICES MARKET FOR CONSUMABLES & ACCESSORIES, BY TYPE, 2023–2030 (USD MILLION) 153 TABLE 90 CANADA: UROLOGY DEVICES MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 153 TABLE 91 CANADA: UROLOGY DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 154 TABLE 92 EUROPE: KEY MACROECONOMIC INDICATORS 155 TABLE 93 EUROPE: UROLOGY DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 156 TABLE 94 EUROPE: UROLOGY DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 156 TABLE 95 EUROPE: UROLOGY DEVICES MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 157 TABLE 96 EUROPE: UROLOGY DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 157 TABLE 97 GERMANY: UROLOGY DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 158 TABLE 98 GERMANY: UROLOGY DEVICES MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION) 159 TABLE 99 GERMANY: UROLOGY DEVICES MARKET FOR CONSUMABLES & ACCESSORIES, BY TYPE, 2023–2030 (USD MILLION) 160 TABLE 100 GERMANY: UROLOGY DEVICES MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 160 TABLE 101 GERMANY: UROLOGY DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 161 TABLE 102 UK: UROLOGY DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 162 TABLE 103 UK: UROLOGY DEVICES MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION) 162 TABLE 104 UK: UROLOGY DEVICES MARKET FOR CONSUMABLES & ACCESSORIES, BY TYPE, 2023–2030 (USD MILLION) 163 TABLE 105 UK: UROLOGY DEVICES MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 163 TABLE 106 UK: UROLOGY DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 164 TABLE 107 FRANCE: UROLOGY DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 165 TABLE 108 FRANCE: UROLOGY DEVICES MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION) 165 TABLE 109 FRANCE: UROLOGY DEVICES MARKET FOR CONSUMABLES & ACCESSORIES, BY TYPE, 2023–2030 (USD MILLION) 166 TABLE 110 FRANCE: UROLOGY DEVICES MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 166 TABLE 111 FRANCE: UROLOGY DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 167 TABLE 112 ITALY: UROLOGY DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 168 TABLE 113 ITALY: UROLOGY DEVICES MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION) 168 TABLE 114 ITALY: UROLOGY DEVICES MARKET FOR CONSUMABLES & ACCESSORIES, BY TYPE, 2023–2030 (USD MILLION) 169 TABLE 115 ITALY: UROLOGY DEVICES MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 169 TABLE 116 ITALY: UROLOGY DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 170 TABLE 117 SPAIN: UROLOGY DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 171 TABLE 118 SPAIN: UROLOGY DEVICES MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION) 171 TABLE 119 SPAIN: UROLOGY DEVICES MARKET FOR CONSUMABLES & ACCESSORIES, BY TYPE, 2023–2030 (USD MILLION) 172 TABLE 120 SPAIN: UROLOGY DEVICES MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 172 TABLE 121 SPAIN: UROLOGY DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 173 TABLE 122 REST OF EUROPE: UROLOGY DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 174 TABLE 123 REST OF EUROPE: UROLOGY DEVICES MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION) 174 TABLE 124 REST OF EUROPE: UROLOGY DEVICES MARKET FOR CONSUMABLES & ACCESSORIES, BY TYPE, 2023–2030 (USD MILLION) 175 TABLE 125 REST OF EUROPE: UROLOGY DEVICES MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 175 TABLE 126 REST OF EUROPE: UROLOGY DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 176 TABLE 127 ASIA PACIFIC: KEY MACROECONOMIC INDICATORS 177 TABLE 128 ASIA PACIFIC: UROLOGY DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 178 TABLE 129 ASIA PACIFIC: UROLOGY DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 178 TABLE 130 ASIA PACIFIC: UROLOGY DEVICES MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 178 TABLE 131 ASIA PACIFIC: UROLOGY DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 179 TABLE 132 CHINA: UROLOGY DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 180 TABLE 133 CHINA: UROLOGY DEVICES MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION) 180 TABLE 134 CHINA: UROLOGY DEVICES MARKET FOR CONSUMABLES & ACCESSORIES, BY TYPE, 2023–2030 (USD MILLION) 181 TABLE 135 CHINA: UROLOGY DEVICES MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 181 TABLE 136 CHINA: UROLOGY DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 182 TABLE 137 JAPAN: UROLOGY DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 183 TABLE 138 JAPAN: UROLOGY DEVICES MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION) 183 TABLE 139 JAPAN: UROLOGY DEVICES MARKET FOR CONSUMABLES & ACCESSORIES, BY TYPE, 2023–2030 (USD MILLION) 184 TABLE 140 JAPAN: UROLOGY DEVICES MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 184 TABLE 141 JAPAN: UROLOGY DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 185 TABLE 142 INDIA: UROLOGY DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 186 TABLE 143 INDIA: UROLOGY DEVICES MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION) 187 TABLE 144 INDIA: UROLOGY DEVICES MARKET FOR CONSUMABLES & ACCESSORIES, BY TYPE, 2023–2030 (USD MILLION) 188 TABLE 145 INDIA: UROLOGY DEVICES MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 188 TABLE 146 INDIA: UROLOGY DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 189 TABLE 147 REST OF ASIA PACIFIC: UROLOGY DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 190 TABLE 148 REST OF ASIA PACIFIC: UROLOGY DEVICES MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION) 190 TABLE 149 REST OF ASIA PACIFIC: UROLOGY DEVICES MARKET FOR CONSUMABLES & ACCESSORIES, BY TYPE, 2023–2030 (USD MILLION) 191 TABLE 150 REST OF ASIA PACIFIC: UROLOGY DEVICES MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 191 TABLE 151 REST OF ASIA PACIFIC: UROLOGY DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 192 TABLE 152 LATIN AMERICA: KEY MACROECONOMIC INDICATORS 192 TABLE 153 LATIN AMERICA: UROLOGY DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 193 TABLE 154 LATIN AMERICA: UROLOGY DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 193 TABLE 155 LATIN AMERICA: UROLOGY DEVICES MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 194 TABLE 156 LATIN AMERICA: UROLOGY DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 194 TABLE 157 BRAZIL: UROLOGY DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 195 TABLE 158 BRAZIL: UROLOGY DEVICES MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION) 195 TABLE 159 BRAZIL: UROLOGY DEVICES MARKET FOR CONSUMABLES & ACCESSORIES, BY TYPE, 2023–2030 (USD MILLION) 196 TABLE 160 BRAZIL: UROLOGY DEVICES MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 196 TABLE 161 BRAZIL: UROLOGY DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 197 TABLE 162 MEXICO: UROLOGY DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 198 TABLE 163 MEXICO: UROLOGY DEVICES MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION) 198 TABLE 164 MEXICO: UROLOGY DEVICES MARKET FOR CONSUMABLES & ACCESSORIES, BY TYPE, 2023–2030 (USD MILLION) 199 TABLE 165 MEXICO: UROLOGY DEVICES MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 199 TABLE 166 MEXICO: UROLOGY DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 200 TABLE 167 REST OF LATIN AMERICA: UROLOGY DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 200 TABLE 168 REST OF LATIN AMERICA: UROLOGY DEVICES MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION) 201 TABLE 169 REST OF LATIN AMERICA: UROLOGY DEVICES MARKET FOR CONSUMABLES & ACCESSORIES, BY TYPE, 2023–2030 (USD MILLION) 202 TABLE 170 REST OF LATIN AMERICA: UROLOGY DEVICES MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 202 TABLE 171 REST OF LATIN AMERICA: UROLOGY DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 203 TABLE 172 MIDDLE EAST & AFRICA: KEY MACROECONOMIC INDICATORS 204 TABLE 173 MIDDLE EAST & AFRICA: UROLOGY DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 204 TABLE 174 MIDDLE EAST & AFRICA: UROLOGY DEVICES MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 205 TABLE 175 MIDDLE EAST & AFRICA: UROLOGY DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 205 TABLE 176 UROLOGY DEVICES MARKET: KEY PLAYER STRATEGIES/RIGHT TO WIN, 2022–2025 206 TABLE 177 UROLOGY DEVICES MARKET: DEGREE OF COMPETITION 209 TABLE 178 UROLOGY DEVICES MARKET: REGION FOOTPRINT 215 TABLE 179 UROLOGY DEVICES MARKET: PRODUCT FOOTPRINT 215 TABLE 180 UROLOGY DEVICES MARKET: DETAILED LIST OF KEY STARTUPS/SMES 217 TABLE 181 UROLOGY DEVICES MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES 217 TABLE 182 UROLOGY DEVICES MARKET: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022–NOVEMBER 2025 218 TABLE 183 UROLOGY DEVICES MARKET: DEALS, JANUARY 2022–NOVEMBER 2025 219 TABLE 184 UROLOGY DEVICES MARKET: EXPANSIONS, JANUARY 2022–NOVEMBER 2025 220 TABLE 185 FRESENIUS MEDICAL CARE AG & CO. KGAA: COMPANY OVERVIEW 221 TABLE 186 FRESENIUS MEDICAL CARE AG & CO. KGAA: PRODUCTS OFFERED 222 TABLE 187 FRESENIUS MEDICAL CARE AG & CO. KGAA: DEALS, JANUARY 2022–NOVEMBER 2025 223 TABLE 188 FRESENIUS MEDICAL CARE AG & CO. KGAA: EXPANSIONS, JANUARY 2022–NOVEMBER 2025 223 TABLE 189 BOSTON SCIENTIFIC CORPORATION: COMPANY OVERVIEW 225 TABLE 190 BOSON SCIENTIFIC CORPORATION: PRODUCTS OFFERED 226 TABLE 191 BOSON SCIENTIFIC CORPORATION: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022–NOVEMBER 2025 228 TABLE 192 BOSON SCIENTIFIC CORPORATION: DEALS, JANUARY 2022–NOVEMBER 2025 229 TABLE 193 B. BRAUN MELSUNGEN AG: COMPANY OVERVIEW 230 TABLE 194 B. BRAUN MELSUNGEN AG: PRODUCTS OFFERED 231 TABLE 195 B. BRAUN MELSUNGEN AG: DEALS, JANUARY 2022–NOVEMBER 2025 233 TABLE 196 BECTON, DICKINSON AND COMPANY: COMPANY OVERVIEW 234 TABLE 197 BECTON, DICKINSON AND COMPANY: PRODUCTS OFFERED 235 TABLE 198 OLYMPUS CORPORATION: COMPANY OVERVIEW 239 TABLE 199 OLYMPUS CORPORATION: PRODUCTS OFFERED 240 TABLE 200 OLYMPUS CORPORATION: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022–NOVEMBER 2025 243 TABLE 201 OLYMPUS CORPORATION: DEALS, JANUARY 2022–NOVEMBER 2025 243 TABLE 202 OLYMPUS CORPORATION: EXPANSIONS, JANUARY 2022–NOVEMBER 2025 243 TABLE 203 CARDINAL HEALTH: COMPANY OVERVIEW 244 TABLE 204 CARDINAL HEALTH: PRODUCTS OFFERED 245 TABLE 205 CARDINAL HEALTH: DEALS, JANUARY 2022–NOVEMBER 2025 246 TABLE 206 INTUITIVE SURGICAL: COMPANY OVERVIEW 247 TABLE 207 INTUITIVE SURGICAL: PRODUCTS OFFERED 248 TABLE 208 INTUITIVE SURGICAL: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022–NOVEMBER 2025 249 TABLE 209 COLOPLAST A/S: COMPANY OVERVIEW 250 TABLE 210 COLOPLAST A/S: PRODUCTS OFFERED 251 TABLE 211 COLOPLAST A/S: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022–NOVEMBER 2025 253 TABLE 212 STRYKER: COMPANY OVERVIEW 254 TABLE 213 STRYKER: PRODUCTS OFFERED 255 TABLE 214 STRYKER: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022–NOVEMBER 2025 256 TABLE 215 TELEFLEX INCORPORATED: COMPANY OVERVIEW 257 TABLE 216 TELEFLEX INCORPORATED: PRODUCTS OFFERED 258 TABLE 217 TELEFLEX INCORPORATED: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022–NOVEMBER 2025 261 TABLE 218 CONVATEC GROUP PLC: COMPANY OVERVIEW 262 TABLE 219 CONVATEC GROUP PLC: PRODUCTS OFFERED 263 TABLE 220 MEDTRONIC PLC: COMPANY OVERVIEW 264 TABLE 221 MEDTRONIC PLC: PRODUCTS OFFERED 265 TABLE 222 MEDTRONIC PLC: EXPANSIONS, JANUARY 2022–NOVEMBER 2025 266 TABLE 223 KARL STORZ: COMPANY OVERVIEW 267 TABLE 224 COOK MEDICAL: COMPANY OVERVIEW 268 TABLE 225 RICHARD WOLF GMBH: COMPANY OVERVIEW 271 TABLE 226 COMPACTCATH: COMPANY OVERVIEW 272 TABLE 227 DORNIER MEDTECH: COMPANY OVERVIEW 273 TABLE 228 NIKKISO CO., LTD.: COMPANY OVERVIEW 274 TABLE 229 DIALIFE SA: COMPANY OVERVIEW 275 TABLE 230 ERBE VISION: COMPANY OVERVIEW 276 TABLE 231 WELL LEAD MEDICAL CO., LTD.: COMPANY OVERVIEW 277 TABLE 232 ROCAMED: COMPANY OVERVIEW 278 TABLE 233 ENDOMED SYSTEMS GMBH: COMPANY OVERVIEW 279 TABLE 234 AMSINO INTERNATIONAL, INC.: COMPANY OVERVIEW 280 TABLE 235 MEDISPEC: COMPANY OVERVIEW 281 TABLE 236 VIMEX SP. Z O.O.: COMPANY OVERVIEW 282 TABLE 237 BALTON SP. Z O.O.: COMPANY OVERVIEW 283 TABLE 238 HUNTER UROLOGY: COMPANY OVERVIEW 284 TABLE 239 RIBBEL INTERNATIONAL LIMITED: COMPANY OVERVIEW 285 FIGURE 1 UROLOGY DEVICES MARKET SEGMENTATION AND REGIONS COVERED 27 FIGURE 2 UROLOGY DEVICES MARKET: RESEARCH DESIGN 32 FIGURE 3 UROLOGY DEVICES MARKET: KEY DATA FROM SECONDARY SOURCES 34 FIGURE 4 LIST OF PRIMARY SOURCES IN UROLOGY DEVICES MARKET 35 FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 36 FIGURE 6 UROLOGY DEVICES MARKET: KEY INSIGHTS FROM PRIMARY EXPERTS 37 FIGURE 7 REVENUE ESTIMATION OF KEY PLAYERS IN UROLOGY DEVICES MARKET 38 FIGURE 8 UROLOGY DEVICES MARKET: CAGR PROJECTIONS 39 FIGURE 9 UROLOGY DEVICES MARKET: TOP-DOWN APPROACH 39 FIGURE 10 UROLOGY DEVICES MARKET: DATA TRIANGULATION 40 FIGURE 11 UROLOGY DEVICES MARKET: PARAMETRIC ASSUMPTIONS 41 FIGURE 12 UROLOGY DEVICES MARKET, BY PRODUCT, 2025 VS. 2030 (USD MILLION) 43 FIGURE 13 UROLOGY DEVICES MARKET, BY APPLICATION, 2025 VS. 2030 (USD MILLION) 44 FIGURE 14 UROLOGY DEVICES MARKET, BY END USER, 2025 VS. 2030 (USD MILLION) 45 FIGURE 15 GEOGRAPHICAL SNAPSHOT OF UROLOGY DEVICES MARKET 46 FIGURE 16 GROWING PREVALENCE OF UROLOGICAL DISEASES AND PREFERENCE FOR MINIMALLY INVASIVE PROCEDURES TO DRIVE MARKET 47 FIGURE 17 HOSPITALS SEGMENT AND CHINA LED ASIA PACIFIC MARKET IN 2024 48 FIGURE 18 CHINA TO BE FASTEST-GROWING MARKET DURING FORECAST PERIOD 49 FIGURE 19 ASIA PACIFIC TO EXHIBIT FASTEST GROWTH DURING FORECAST PERIOD 50 FIGURE 20 UROLOGY DEVICES MARKET DYNAMICS: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 51 FIGURE 21 CANADA: NUMBER OF TOTAL INCIDENTS OF END-STAGE RENAL DISEASE PATIENTS, BY AGE GROUP, 2022 53 FIGURE 22 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS IN UROLOGY DEVICES MARKET 58 FIGURE 23 UROLOGY DEVICES MARKET: VALUE CHAIN ANALYSIS 61 FIGURE 24 UROLOGY DEVICES MARKET: SUPPLY CHAIN ANALYSIS 62 FIGURE 25 UROLOGY DEVICES MARKET: ECOSYSTEM ANALYSIS 64 FIGURE 26 UROLOGY DEVICES MARKET: FUNDING AND NUMBER OF DEALS, 2020–2025 (USD MILLION) 65 FIGURE 27 UROLOGY DEVICES MARKET: PATENT ANALYSIS, 2015–2024 68 FIGURE 28 UROLOGY DEVICES MARKET: PORTER’S FIVE FORCES ANALYSIS 76 FIGURE 29 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE END USERS 79 FIGURE 30 KEY BUYING CRITERIA FOR TOP THREE END USERS 79 FIGURE 31 IMPACT OF AI ON UROLOGY DEVICES MARKET 81 FIGURE 32 NORTH AMERICA: UROLOGY DEVICES MARKET SNAPSHOT 145 FIGURE 33 ASIA PACIFIC: UROLOGY DEVICES MARKET SNAPSHOT 177 FIGURE 34 REVENUE ANALYSIS OF KEY PLAYERS, 2022–2024 (USD MILLION) 207 FIGURE 35 MARKET SHARE ANALYSIS OF KEY PLAYERS, 2024 208 FIGURE 36 US: MARKET SHARE ANALYSIS OF KEY PLAYERS, 2024 210 FIGURE 37 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND FIVE-YEAR STOCK BETA OF KEY VENDORS 211 FIGURE 38 EV/EBITDA OF KEY VENDORS 212 FIGURE 39 UROLOGY DEVICES MARKET: BRAND/PRODUCT COMPARISON 212 FIGURE 40 UROLOGY DEVICES MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024 214 FIGURE 41 UROLOGY DEVICES MARKET: COMPANY FOOTPRINT 214 FIGURE 42 UROLOGY DEVICES MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024 216 FIGURE 43 FRESENIUS MEDICAL CARE AG & CO. KGAA: COMPANY SNAPSHOT (2024) 222 FIGURE 44 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2024) 226 FIGURE 45 B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT (2024) 231 FIGURE 46 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2024) 235 FIGURE 47 OLYMPUS CORPORATION: COMPANY SNAPSHOT (2024) 240 FIGURE 48 CARDINAL HEALTH: COMPANY SNAPSHOT (2024) 245 FIGURE 49 INTUITIVE SURGICAL: COMPANY SNAPSHOT (2024) 248 FIGURE 50 COLOPLAST A/S: COMPANY SNAPSHOT (2024) 251 FIGURE 51 STRYKER: COMPANY SNAPSHOT (2024) 255 FIGURE 52 TELEFLEX INCORPORATED: COMPANY SNAPSHOT (2024) 258 FIGURE 53 CONVATEC GROUP PLC: COMPANY SNAPSHOT (2024) 263 FIGURE 54 MEDTRONIC PLC: COMPANY SNAPSHOT (2024) 265